Skip to main content

Alport's Syndrome clinical trials at UC Health
1 in progress, 0 open to eligible people

  • Study of SAR339375 in Patients With Alport Syndrome

    Sorry, currently not accepting new patients, but might later

    Primary Objectives: - To assess the efficacy of SAR339375 in reducing the decline in renal function - To assess the safety and tolerability of SAR339375 Secondary Objectives: - To assess plasma pharmacokinetic (PK) parameters of the parent compound and its metabolites - To assess the immunogenicity of the SAR339375

    at UCLA

Last updated: